AROA BIOSURGERY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.495 AUD | -1.00% |
|
-2.94% | -40.36% |
| 04-30 | Transcript : Aroa Biosurgery Limited, Q4 2024 Earnings Call, Apr 30, 2024 | |
| 01-29 | Transcript : Aroa Biosurgery Limited, Q3 2024 Earnings Call, Jan 30, 2024 |
Presenter SpeechNeetha Alex-Kumar (Executives)Okay. Thank you for your patience. We will kick ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Aroa Biosurgery Limited is a soft-tissue regeneration company. It develops, manufactures, sells, and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Its products are developed from the AROA extracellular matrix (ECM) technology platform, an extracellular matrix biomaterial derived from ovine forestomach. AROA ECM is an ECM biomaterial containing a rich and complex mix of biological molecules that is the building block for a range of soft tissue repair products. Its products include Endoform, Myriad Matrix, Myriad Morcells, Myriad Morcells Fine, and Reinforced Bioscaffolds. Endoform products support all phases of wound healing and are appropriate for use early in wound management to restore protease balance and advance healing to the proliferative phase. Myriad Matrix is an engineered ECM for soft tissue repair, reinforcement and complex wounds. Its subsidiaries are Aroa Biosurgery Incorporated and Mesynthes Nominee Limited.
Calendar
20/05/2024
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5395
NZD
Average target price
1.108
NZD
Spread / Average Target
+105.35%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -40.36% | 115M | |
| +10.10% | 27.55B | |
| -30.75% | 3.13B | |
| +35.19% | 2.66B | |
| -18.85% | 2.43B | |
| +6.85% | 2.27B | |
| -4.71% | 2.08B | |
| +33.33% | 2.05B | |
| +34.05% | 1.35B | |
| +3.25% | 1.34B |
- Stock Market
- Equities
- ARX Stock
- News Aroa Biosurgery Limited
- Transcript : Aroa Biosurgery Limited, Q4 2024 Earnings Call, Apr 30, 2024
